Burch, P A <br/><br/>
Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Cancer Treatment Group Trial.  [electronic resource] 

 -  American journal of clinical oncology  Oct 2000 
 - 534-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0277-3732 
<br/><br/><label>Standard No.: </label>10.1097/00000421-200010000-00021  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Dipyridamole--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Leucovorin--administration & dosage<br/>Male<br/>Middle Aged<br/>Mitomycin--administration & dosage<br/>Pancreatic Neoplasms--drug therapy<br/>Survival Analysis<br/>Treatment Failure